Patent · US Active

Quinazolinones as bromodomain inhibitors

US10500209B2 · kind B2 · utility

0Cited by
33References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 22, 2017
Grant dateDec 10, 2019
Priority date—
Expiry dateNov 22, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.